Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression

World Journal of Biological Psychiatry

Volumn 15, Issue 1, 2014, Pages 76-82

  Kaminitz, Ayelet ^a   Barzilay, Ran ^a,b   Segal, Hadar ^b   Taler, Michal ^a   Offen, Daniel ^b   Gil Ad, Irit ^a   Mechoulam, Raphael ^c   Weizman, Abraham ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Animal model; BDNF; CB1; DISC1; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CANNABINOID 1 RECEPTOR; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTISOCIAL BEHAVIOR; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; RECOGNITION; SCHIZOPHRENIA; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; WESTERN BLOTTING;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; GENES, DOMINANT; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; PREFRONTAL CORTEX; RECEPTOR, CANNABINOID, CB1; RECEPTOR, TRKB; SCHIZOPHRENIA; SOCIAL BEHAVIOR;

EID: 84892398426     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2013.841993     Document Type: Article

References (40)

1. Abazyan B, Nomura J, Kannan G, Ishizuka K, Tamashiro KL, Nucifora F, et al. 2010. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68: 1172-1181.
2. Abazyan B, Dziedzic J, Hua K, Abazyan S, Yang C, Mori S, et al. 2013. Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study. Schizophr Bull. In press.
3. Arnold JC, Boucher AA, Karl T. 2012. The yin and yang of cannabis-induced psychosis: the actions of (9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. Curr Pharm Des 18: 5113-5130.
4. Aso E, Ozaita A, Valdiz á n EM, Ledent C, Pazos A, Maldonado R, et al. 2008. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem 105: 565-572. (Pubitemid 351490016)
5. Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, et al. 2012. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry 17: 887-905.
6. Ayhan Y, Abazyan B, Nomura J, Kim R, Ladenheim B, Krasnova IN, et al. 2011. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry 16: 293-306.
7. Barzilay R, Ben-Zur T, Sadan O, Bren Z, Taler M, Lev N, et al. 2011. Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social defi cit in mice. Transl Psychiatry 1: e61.
8. Beyer CE, Dwyer JM, Piesla MJ, Platt BJ, Shen R, Rahman Z, et al. 2010. Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiol Dis 39: 148-155.
9. Bossong MG, Niesink RJM. 2010. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 92: 370-385.
10. Brandon NJ, Sawa A. 2011. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci 12: 707-722.
11. Butovsky E, Juknat A, Goncharov I, Elbaz J, Eilam R, Zangen A, et al. 2005. In vivo up-regulation of brain-derived neurotrophic factor in specifi c brain areas by chronic exposure to Deltatetrahydrocannabiol. J Neurochem 93: 802-811. (Pubitemid 40695740)
12. De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, et al. 2010. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci 20: 8127-8137.
13. Decoster J, Van Os J, Kenis G, Henquet C, Peuskens J, De Hert M, et al. 2011. Age at onset of psychotic disorder: Cannabis, BDNF Val66Met, and sex-specifi c models of gene environment interaction. Am J Med Genet B Neuropsychiatr Gene 156: 363-369.
14. D ' Souza DC, Pittman B, Perry E, Simen A. 2009. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology (Berlin) 202: 569-578.
15. Eggan SM, Hashimoto T, Lewis DA. 2008. Reduced cortical cannabinoid 1 receptor messenger rna and protein expression in schizophrenia. Arch Gen Psychiatry 65: 772-784. (Pubitemid 351957703)
16. Fattore L, Fratta W. 2010. How important are sex differences in cannabinoid action Br J Pharmacol 160: 544-548.
17. Favalli G, Li J, Belmonte-de-Abreu P, Wong AHC, Daskalakis ZJ. 2012. The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 46: 1-11.
18. Fernandez-Espejo E, Viveros MP, Nunez L, Ellenbroek BA, Rodriguez de Fonseca F. 2009. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berlin) 206: 531-549.
19. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. 2011. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry 16: 960-972.
20. Guo C, Yang Y, Su Y, Si T. 2010. Postnatal BDNF expression profi les in prefrontal cortex and hippocampus of a rat schizophrenia model induced by MK-801 administration. J Biomed Biotechnol 2010: 783297.
21. Haque FN, Lipina TV, Roder JC, Wong AHC. 2012. Social defeat interacts with Disc1 mutations in the mouse to affect behavior. Behav Brain Res 233: 337-344.
22. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, et al. 2007. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 104: 14501-14506. (Pubitemid 350003290)
23. Ibi D, Nagai T, Kitahara Y, Mizoguchi H, Koike H, Shiraki A, et al. 2009. Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. Neurosci Res 64: 297-305.
24. Jaaro-Peled H. 2009. Gene models of schizophrenia: DISC1 mouse models. Prog Brain Res 179: 75-86.
25. Kilpinen H, Ylisaukko-oja T, Hennah W, Palo OM, Varilo T, Vanhala R, et al. 2007. Association of DISC1 with autism and Asperger syndrome. Mol Psychiatry 13: 187-196.
26. Le Strat Y, Ramoz N, Gorwood P. 2009. The role of genes involved in neuroplasticity and neurogenesis in the observation of a gene-environment interaction (GxE) in schizophrenia. Curr Mol Med 9: 506-518.
27. Lipina TV, Zai C, Hlousek D, Roder JC, Wong AH. 2013. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J Neurosci 33: 7654-7666.
28. Lipska BK, Khaing ZZ, Weickert CS, Weinberger DR. 2001. BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur J Neurosci 14: 135-144. (Pubitemid 32738482)
29. Marongiu MF, Poddie D, Porcu S, Manchinu MF, Castelli MP, Sogos V, et al. 2012. Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/-mice. PLoS ONE 7: e35013.
30. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CAM, et al. 2000. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9: 1415-1423. (Pubitemid 30312490)
31. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. 2007. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319-328. (Pubitemid 47094993)
32. Muller-Vahl KR, Emrich HM. 2008. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Expert Rev Neurother 8: 1037-1048. (Pubitemid 351962072)
33. Nadler JJ, Moy SS, Dold G, Simmons N, Perez A, Young NB, et al. 2004. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 3: 303-314. (Pubitemid 39277417)
34. Nagai T, Ibi D, Yamada K. 2011. Animal model for schizophrenia that refl ects gene-environment interactions. Biol Pharm Bull 34: 1364-1368.
35. Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y, et al. 2013. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 339: 335-339.
36. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov MV, Huang H, et al. 2007. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 13: 173-186.
37. Pogorelov VM, Nomura J, Kim J, Kannan G, Ayhan Y, Yang C, et al. 2012. Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology 62: 1242-1251.
38. Smith MA, Makino S, Kim SY, Kvetnansky R. 1995. Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology 136: 3743-3750.
39. Thompson Ray M, Weickert CS, Wyatt E, Webster MJ. 2011. Decreased BDNF, trkB-TK-and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36: 195-203.
40. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. 2003. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8: 592-610. (Pubitemid 36898018)